Health Policy as a Barrier to First Nations Peoples' Access to Cancer Screening.


Journal

Healthcare policy = Politiques de sante
ISSN: 1715-6580
Titre abrégé: Healthc Policy
Pays: Canada
ID NLM: 101280107

Informations de publication

Date de publication:
02 2020
Historique:
entrez: 17 3 2020
pubmed: 17 3 2020
medline: 16 7 2021
Statut: ppublish

Résumé

First Nations peoples in Ontario are facing increasing rates of cancer and have been found to have poorer survival. Cancer screening is an important strategy to improve cancer outcomes; yet, Indigenous people in Canada are less likely to participate in screening. Ontario has established organized breast, cervical and colorectal cancer screening programs; this paper examines the health policy context that informs these programs for First Nations peoples in the province. This paper follows an embedded multiple-case study design, drawing upon a document review to outline the existing policy context and on key informant interviews to explore the aforementioned context from the perspective of stakeholders. Policies created by agencies operating across federal, regional and provincial levels impact First Nations peoples' access to screening. Interviews identified issues of jurisdictional ambiguity, appropriateness of program design for First Nations persons and lack of cultural competency as barriers to participation in screening. Federal, provincial and regional policy makers must work in collaboration with First Nations peoples to overcome barriers to cancer screening created and sustained by existing policies.

Sections du résumé

BACKGROUND
First Nations peoples in Ontario are facing increasing rates of cancer and have been found to have poorer survival. Cancer screening is an important strategy to improve cancer outcomes; yet, Indigenous people in Canada are less likely to participate in screening. Ontario has established organized breast, cervical and colorectal cancer screening programs; this paper examines the health policy context that informs these programs for First Nations peoples in the province.
METHOD
This paper follows an embedded multiple-case study design, drawing upon a document review to outline the existing policy context and on key informant interviews to explore the aforementioned context from the perspective of stakeholders.
RESULTS
Policies created by agencies operating across federal, regional and provincial levels impact First Nations peoples' access to screening. Interviews identified issues of jurisdictional ambiguity, appropriateness of program design for First Nations persons and lack of cultural competency as barriers to participation in screening.
CONCLUSION
Federal, provincial and regional policy makers must work in collaboration with First Nations peoples to overcome barriers to cancer screening created and sustained by existing policies.

Identifiants

pubmed: 32176609
pii: hcpol.2020.26132
doi: 10.12927/hcpol.2020.26132
pmc: PMC7075447
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

28-46

Informations de copyright

Copyright © 2020 Longwoods Publishing.

Références

J Transcult Nurs. 2009 Jan;20(1):83-92
pubmed: 18669899
Arctic Med Res. 1991;Suppl:447-51
pubmed: 1365188
Public Health Rev. 2016 Jul 20;37:2
pubmed: 29450044
Int J Cancer. 2015 Feb 1;136(3):639-45
pubmed: 24923728
Int J Circumpolar Health. 2013 Dec 27;72:22690
pubmed: 24380077
CMAJ. 2013 Jan 8;185(1):35-45
pubmed: 23297138
Int J Gen Med. 2011;4:699-709
pubmed: 22069372
Can J Nurs Res. 2018 Dec;50(4):202-213
pubmed: 29665703
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):145-151
pubmed: 27965294
Am J Public Health. 1983 May;73(5):515-20
pubmed: 6837814
CMAJ. 2016 Mar 15;188(5):340-348
pubmed: 26903355
J Racial Ethn Health Disparities. 2019 Feb;6(1):37-45
pubmed: 29736617
BMC Health Serv Res. 2016 Aug 18;16(1):402
pubmed: 27538389
Health Rep. 2009 Dec;20(4):31-51
pubmed: 20108604
West J Nurs Res. 2001 Mar;23(2):126-47
pubmed: 11272853
Can J Gastroenterol Hepatol. 2016;2016:2878149
pubmed: 27597935
Ann Intern Med. 2016 Feb 16;164(4):244-55
pubmed: 26756588
J Empir Res Hum Res Ethics. 2013 Apr;8(2):129-40
pubmed: 23651937
Can J Public Health. 2010 Jan-Feb;101(1):101-5
pubmed: 20364549
Healthc Pap. 2005;5(4):43-51
pubmed: 16088309
Paediatr Child Health. 2015 Mar;20(2):62-4
pubmed: 25838774
Chronic Dis Inj Can. 2014 Jul;34(2-3):103-12
pubmed: 24991773
CMAJ. 2012 Nov 6;184(16):1803-7
pubmed: 22966059
Health Place. 2011 Jan;17(1):386-9
pubmed: 21074479
Lancet. 2009 Jul 4;374(9683):76-85
pubmed: 19577696
CMAJ. 2011 Nov 22;183(17):1991-2001
pubmed: 22106103
BMC Med Ethics. 2016 Oct 6;17(1):56
pubmed: 27716156
Can J Nurs Res. 2005 Dec;37(4):38-60
pubmed: 16541818
N Engl J Med. 2015 Jun 11;372(24):2353-8
pubmed: 26039523
Cancer Causes Control. 2003 Apr;14(3):259-68
pubmed: 12814205

Auteurs

Joshua K Tobias (JK)

Partnership Liaison Officer, Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON.

Jill Tinmouth (J)

Lead Scientist, ColonCancerCheck Program, Ontario Health (Cancer Care Ontario), Toronto, ON, Scientist and Staff Gastroenterologist, Sunnybrook Health Sciences, Toronto, ON.

Laura C Senese (LC)

Research Project Coordinator, Sunnybrook Research Institute, Toronto, ON, Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON.

Naana Jumah (N)

Assistant Professor, Northern Ontario School of Medicine, Thunder Bay, ON.

Diego Llovet (D)

Scientist, Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON, Institute of Health Policy, Management and Evaluation/Dalla Lana School of Public Health, University of Toronto, Toronto, ON.

Alethea Kewayosh (A)

Director, Indigenous Cancer Care Unit, Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON.

Linda Rabeneck (L)

Vice President, Prevention & Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, ON.

Mark Dobrow (M)

Associate Professor, Institute of Health Policy, Management and Evaluation/Dalla Lana School of Public Health, University of Toronto, Toronto, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH